出口止跌回稳,但结构分化
上半年中药类出口 26.1 亿美元、同比 +2.1%,结束连续三年下滑;增量主要来自保健品(+19.8%),占比近六成的植物提取物仍在小幅下降。
政策、标准、贸易与价格:中药产业链上正在发生的变化,以及一家道地药材供应商能怎么用。
Policy, standards, trade and prices — what is changing across the TCM supply chain, and what it means for a grower-region supplier.
覆盖 2026 年 9—11 月,兼顾年内关键政策与标准节点 · 数据截至 2026-11-21
Covering September–November 2026, plus the year's key policy and standards milestones · Data as of 21 November 2026
这一期所有信息,都可以归到三句话上:出口在回稳、标准在收紧、原料在降价。
上半年中药类出口 26.1 亿美元、同比 +2.1%,结束连续三年下滑;增量主要来自保健品(+19.8%),占比近六成的植物提取物仍在小幅下降。
ISO/TC 249 已发布 135 项中医药国际标准。2026 年新增标准物质、种植与初加工、饮片处方三项,国际贸易的比对标尺正由中国参与定义。
黄连、当归、党参价格较 2025 年高位明显回落,采购方议价空间变大;对供货方来说,锁价周期不宜过长。
Everything in this brief comes down to three sentences: exports are stabilising, standards are tightening, raw materials are cheaper.
H1 2026 TCM exports reached USD 2.61 billion, up 2.1% year on year, ending three years of decline. Growth came from health products (+19.8%); plant extracts, nearly 60% of the total, still edged down.
ISO/TC 249 has published 135 TCM international standards. Three were added in 2026 — reference materials, cultivation and primary processing, and decoction-piece prescriptions. The yardstick for trade is increasingly defined with Chinese input.
Coptis, angelica and codonopsis have fallen well below their 2025 highs. Buyers have more room to negotiate, and suppliers should avoid long price locks.
| 事项 | 时间 | 要点 | 对我们的影响 |
|---|---|---|---|
| 美国 FDA 警告函 | 2026-10-23 | 指得州经销商 Best Chinese Medicines 网售的五款中药宣称疗效,属"未经批准的新药",要求整改 | 出口美国时"功效宣称"是红线,原料与饮片不得带治疗表述 |
| FDA / EMA 联合工作坊 | 2026-09-25 | 双方就草药药品、植物药开发的监管路径做对照说明 | 欧美证据要求仍在差异,成药出口需按目的地分别准备 |
| 八部门"中药现代化出海专项" | 2026-02 | 第 15 条明确"支持开拓国际市场" | 政策窗口开启,可关注地方配套与出口便利化措施 |
| 国务院《中医药振兴发展"十五五"规划》 | 2026-07 | 将中医药全球化、现代化、标准化列为国家级战略 | 未来五年国际标准、海外注册、海外中心是政策主线 |
| 跨境 BD 首单 | 2026-07-21 | 梦阳药业将生白口服液美国独家商业化权益授给 TCMG,20 年;基础对价最高 300 万美元,潜在对价最高 7000 万美元 | 中药出海多了一条"授权商业化"的路径,不必自己扛注册 |
| Item | Date | What happened | What it means for us |
|---|---|---|---|
| US FDA warning letter | 23 Oct 2026 | Texas-based distributor Best Chinese Medicines was cited for five products sold online with disease claims, deemed unapproved new drugs; corrective action ordered | Disease claims are the red line for US exports; raw materials and decoction pieces must carry no therapeutic claims |
| FDA / EMA joint workshop | 25 Sep 2026 | The two regulators compared pathways for herbal medicinal and botanical drug development | Evidence requirements still differ; finished-product exports need separate dossiers per market |
| Eight-ministry modernisation and export initiative | Feb 2026 | Article 15 explicitly supports opening international markets | The policy window is open; watch local incentives and export facilitation |
| State Council 15th Five-Year Plan for TCM | Jul 2026 | Globalisation, modernisation and standardisation elevated to national strategy | International standards, overseas registration and overseas centres remain the policy focus for the next five years |
| First cross-border licensing deal | 21 Jul 2026 | Mengyang Pharma licensed US commercialisation rights for Sheng Bai Oral Liquid to TCMG for 20 years: up to USD 3 million base plus up to USD 70 million in potential consideration | A new route — license commercialisation instead of carrying the full registration burden alone |
截至 2026-11-21。价格单位:元/公斤。
| 品种 | 最新价 | 周环比 | 同比 | 备注 |
|---|---|---|---|---|
| 黄连 | 300 | -6.25% | -4.76% | 2026 年 5—6 月高点 370,8—9 月低点 300 |
| 当归 | 38 | 0.00% | -39.68% | 岷县 11-18:药厂货 20.5、小条 23.5、中条 28.5、大条 35 |
| 党参 | 22.5—44.5 | — | — | 岷县 11-18 按规格:0.4cm 以下 22.5、0.4—0.6 26、0.6—0.8 32.5、0.8—1.0 44.5 |
定西指数 7 月月报显示,党参、当归、黄芪价格指数环比分别 -3.84%、-9.19%、-15.97%。需求淡季叠加产地货源充裕,短期仍以弱势震荡为主。
As of 21 November 2026. Prices in CNY per kilogram.
| Variety | Price | w/w | y/y | Notes |
|---|---|---|---|---|
| Coptis Coptis chinensis | 300 | −6.25% | −4.76% | 2026 high of 370 in May–June; low of 300 in August–September |
| Angelica Angelica sinensis | 38 | 0.00% | −39.68% | Minxian, 18 Nov: factory grade 20.5, small 23.5, medium 28.5, large 35 |
| Codonopsis Codonopsis pilosula | 22.5–44.5 | — | — | Minxian, 18 Nov by size: under 0.4cm 22.5; 0.4–0.6 26; 0.6–0.8 32.5; 0.8–1.0 44.5 |
The Dingxi index for July showed codonopsis, angelica and astragalus down 3.84%, 9.19% and 15.97% month on month. Off-season demand and ample supply keep prices weak in the near term.
黄连一周跌 6.25%,长周期锁价风险大;建议按"周度报价 + 单批次锁价"执行,大单再谈季度区间。
同比 -39.68%,产地货源充裕,可与老客户谈年度供货量、价格随行就市,用数量换稳定。
同一天 0.4cm 以下 22.5、0.8—1.0 44.5,价差近一倍;分级挑拣的投入能直接换成毛利。
一是 ISO 24898 的种植与初加工记录,二是"不得宣称疗效"。做海外客户时,以中药材、饮片身份切入,先解决农残、重金属与批次一致性。
Coptis fell 6.25% in a week; long lock-ins are risky. Use weekly quotes plus per-batch price locks, and reserve quarterly ranges for large orders only.
Down 39.68% year on year with ample supply. Agree annual volumes with regular buyers and let prices follow the market — trade quantity for stability.
On the same day, under-0.4cm stock was 22.5 while 0.8–1.0cm reached 44.5 — nearly double. Grading and sorting converts directly into margin.
First, cultivation and primary-processing records under ISO 24898. Second, no therapeutic claims. Enter as medicinal materials or decoction pieces, and solve pesticide residues, heavy metals and batch consistency first.
聚跬同时供应两种形态:既可按原药材整批发货,也可按需加工成饮片。货源来自湖北利川海拔千米以上的富硒高山带,欢迎国内外客户下单、或直接在线询价。
黄连、当归、党参的统货与分级货,供药厂投料、提取与配方使用;编织袋 25kg / 50kg,可按批次锁价、按交期发货。
按药典片型切片、干燥、筛选,可做净制与炮制加工;纸箱或袋装,按客户规格分装贴标,供连锁、门诊与配方使用。
货源在湖北利川海拔千米以上的富硒高山带,产地直采、上海集散。报价与交期:报品种、规格、数量与目的地,当天回复;海外订单可配出口单证、商检与海运/空运方案,支持先寄样。
抖音/微信与手机同号 156 0173 7538,添加或私信请备注“药材询价”。
Kungz supplies in two formats: whole raw medicinal materials by the batch, or processed into decoction pieces on request. Stock comes from the selenium-rich highlands above 1,000 m in Lichuan, Hubei. Buyers worldwide are welcome to order or ask for a quote online.
Coptis, angelica and codonopsis in bulk or graded lots for extraction, formulation and manufacturing. 25 kg / 50 kg woven bags; per-batch price locks and scheduled delivery.
Sliced to pharmacopoeial specifications, dried, sorted, with cleaning and processing options. Cartons or bags, packed and labelled to your specification for chains, clinics and dispensing.
All stock comes from the selenium-rich highlands above 1,000 m in Lichuan, Hubei — sourced at origin, consolidated in Shanghai. Quotes and lead times: send species, grade, quantity and destination — we reply the same day. Export documentation, inspection and sea/air freight can be arranged, and samples can be sent first.
Douyin, WeChat and mobile share one number: +86 156 0173 7538. Please mention "herb enquiry" when you add or message us.
| 机构 | 能帮上什么 | 电话 | 邮箱 |
|---|---|---|---|
| 中国中药协会 | 行业标准、团体标准立项、展会与会员资源 | 010-64060498 | zgzyxh@catcm.org.cn |
| 中国医药保健品进出口商会 | 出口数据、海外渠道、国际合规培训 | 010-58036286 010-58036283 | liuwh@cccmhpie.org.cn cccinfo@cccmhpie.org.cn |
| 世界中医药学会联合会 | 国际标准、海外学术与团体网络 | 010-58650235 010-58650036 | zhb_wfcms@vip.163.com |
| 上海聚跬实业有限公司 | 本方联系人 | 156 0173 7538 | g15601737538@gmail.com |
上述均为机构公开的总机与公务邮箱,官方渠道一般不公布个人手机号;需要具体对接人,建议先发邮件说明来意。
| Organisation | What they can help with | Phone | |
|---|---|---|---|
| China Association of Traditional Chinese Medicine | Industry standards, association standards, exhibitions and membership | +86 10 6406 0498 | zgzyxh@catcm.org.cn |
| China Chamber of Commerce for Import & Export of Medicines & Health Products | Export data, overseas channels, international compliance training | +86 10 5803 6286 +86 10 5803 6283 | liuwh@cccmhpie.org.cn cccinfo@cccmhpie.org.cn |
| World Federation of Chinese Medicine Societies | International standards, overseas academic and society networks | +86 10 5865 0235 +86 10 5865 0036 | zhb_wfcms@vip.163.com |
| Shanghai Kungz Co., Ltd. | Our own contact | +86 156 0173 7538 | g15601737538@gmail.com |
These are public switchboard numbers and official mailboxes. Individual mobile numbers are generally not published by these institutions; email first with a clear subject line to reach the right person.